Business Context and Reporting Period
This Form 8-K was filed by WellPoint, Inc. (now Elevance Health, Inc.) on September 10, 2012, reporting events occurring on September 5, 2012. The filing details the closing of a significant debt offering to fund corporate activities.
Key Financial Metrics
The Company issued four series of senior notes with an aggregate principal amount of $3.25 billion. The anticipated net proceeds from the sale are approximately $3.21 billion after deducting underwriting discounts and offering expenses.
- 2015 Notes: $625 million principal, 1.250% interest rate, maturing September 10, 2015.
- 2018 Notes: $625 million principal, 1.875% interest rate, maturing January 15, 2018.
- 2023 Notes: $1 billion principal, 3.300% interest rate, maturing January 15, 2023.
- 2043 Notes: $1 billion principal, 4.650% interest rate, maturing January 15, 2043.
The filing text does not provide specific values for revenue, profit, cash flow, margins, or existing debt levels prior to this transaction.
Material Changes and Use of Proceeds
The primary material change is the incurrence of $3.25 billion in new long-term debt. The Company intends to use approximately $3.1 billion of the net proceeds to pay a portion of the consideration for the previously announced acquisition of AMERIGROUP Corporation. The remaining balance will be used for general corporate purposes.
Outlook, Risks, and Contingencies
Redemption Contingency: If the Amerigroup Acquisition is not consummated by September 9, 2013, or if the merger agreement is terminated prior to that date, the Company is obligated to redeem all Notes at 101% of the principal amount plus accrued interest.
Change of Control: Upon a change of control and a subsequent downgrade of the Notes below investment grade by Moody's, S&P, and Fitch, the Company must make an offer to purchase the Notes at 101% of the principal amount plus accrued interest.
Default Events: Events of default include failure to pay principal or interest, breach of indenture terms, or bankruptcy proceedings.
Underwriters: Citigroup Global Markets Inc., Credit Suisse Securities (USA) LLC, and Deutsche Bank Securities Inc. acted as representatives for the underwriters.
Investor Verification Checklist
- Verify the final closing date and actual net proceeds received versus the anticipated $3.21 billion.
- Confirm the status of the Amerigroup Corporation acquisition to assess the risk of the mandatory redemption clause.
- Review the full Underwriting Agreement (Exhibit 1.1) and Indenture (Exhibit 4.1) for detailed covenants and restrictions.
- Check the Computation of Ratio of Earnings to Fixed Charges (Exhibit 12.1) to understand the impact on leverage.
- Monitor credit rating actions by Moody's, S&P, and Fitch regarding the new Notes.